Eli Lilly Becomes First Healthcare Company to Reach $1 Trillion Valuation

Eli Lilly made history today by becoming the first pharmaceutical and healthcare company to reach a $1 trillion market capitalization, propelled by extraordinary global demand for its weight-loss drugs, including Mounjaro and Zepbound.

The milestone positions Lilly alongside an elite group traditionally dominated by technology giants and Berkshire Hathaway, marking a transformative moment for the healthcare sector and signaling the growing economic impact of GLP-1 therapies.

**Notable Headlines**

* **10:51** WSJ: Lilly hits $1T market cap, joining exclusive group of mostly tech companies
* **10:44** Yahoo Finance: $LLY touches $1 trillion; trillion-dollar club expands beyond tech
* **10:40** MarketWatch: Lilly briefly joins $1 trillion market-cap club
* **10:22** WSJ: Weight-loss boom propels Lilly into trillion-dollar territory
* **10:04** Reuters: Eli Lilly hits $1T market value, underscoring weight-loss dominance
* **10:03** Investing.com: *ELI LILLY BECOMES FIRST HEALTH-CARE COMPANY WORTH $1 TRILLION*